Portfolio - 2050 Capital - Tech Investments
Summary
We focus on enterprise software (with a deep science component), computational biotech, and engineering and science ventures (eg quantum/photonics, robotics, advanced materials).Our portfolio is concentrated in the UK and Europe and we provide a bridge to the USA and Asia.
Funding
Amount
-
Total raised
Date
January 1, 2016
Announcement date
Investors
-
Lead investors
Company
http://www.docxpresso.com
Funded company
Classifications
industries
No industries detected
applications
Data Management
AskAI Classifications
Labels
SaaS
Document Automation
Contract Management
Linked Companies
Docxpresso
$1M to $5M